Selegiline Hydrochloride - Pharmaceutical Grade for Parkinson's Disease & Depression Treatment
ProcurenetShort description
Pharmaceutical grade Selegiline Hydrochloride is a potent remedy for Parkinson’s Disease and Major Depressive Disorder. Each effective 5mg tablet is manufactured to strict global standards, ensuring high quality and efficacy. Key attributes include:
- Use: Treatment of Parkinson’s Disease and Major Depressive Disorder
- Grade: Pharmaceutical, guaranteeing top quality
- Specification: Assay (HPLC) >99.0%, meeting the stringency of global standards
- Storage: Store at room temperature, away from moisture and sunlight
Follow professional medical advice before use and secure from children and pets.
-
Procurenet Team Tshim Sha Tsui
Hong Kong
3 years
Description
Selegiline Hydrochloride - Pharmaceutical Grade for Treating Parkinson's Disease and Depression
Selegiline Hydrochloride is a highly effective pharmaceutical compound recognized worldwide for its considerable therapeutic benefits, particularly in the treatment of Parkinson's Disease and depression. This quality, pharmaceutical-grade product demonstrates impressive efficacy and has a well-established presence across global markets.
Selegiline Hydrochloride operates as a selective and irreversible monoamine oxidase (MAO) inhibitor, specifically Type B. Its inhibition of the enzyme increases dopamine levels in the brain, offering symptomatic relief for Parkinson's Disease and depression.
Key Features
- Pharmacological Class: Irreversible MAO-B inhibitors
- Molecular Formula: C13H17N·ClH
- CAS Number: 14611-51-9
- Molecular Weight: 223.74 g/mol
- Boiling Point: 271.7°C
- Refractive Index: 1.570
- Solubility: Soluble in Methanol
- Hazard Statements: H302, H317
- Precautionary Statements: P202, P280, P309+P311
- GHS Classification: Health Hazard
- Routes of Exposure: Ingestion and skin contact
- LD50: 243 mg/kg (Oral - Rat)
- Therapeutic Uses: Predominantly used for the treatment of Parkinson's Disease and depression
